Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

STARD13 antibody (AA 544-573)

STARD13 Reactivity: Human WB Host: Rabbit Polyclonal RB40830 unconjugated
Catalog No. ABIN1881846
  • Target See all STARD13 Antibodies
    STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
    Binding Specificity
    • 6
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    AA 544-573
    Reactivity
    • 23
    • 6
    • 2
    Human
    Host
    • 23
    Rabbit
    Clonality
    • 23
    Polyclonal
    Conjugate
    • 9
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This STARD13 antibody is un-conjugated
    Application
    • 16
    • 12
    • 6
    • 3
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.
    Clone
    RB40830
    Isotype
    Ig Fraction
    Top Product
    Discover our top product STARD13 Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Zhang, Wang, Hu: "STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas." in: Biotechnology letters, Vol. 39, Issue 2, pp. 207-217, (2017) (PubMed).

    Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

  • Target
    STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
    Alternative Name
    STARD13 (STARD13 Products)
    Synonyms
    ARHGAP37 antibody, DLC2 antibody, GT650 antibody, LINC00464 antibody, RGD1564816 antibody, StAR related lipid transfer domain containing 13 antibody, StAR-related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer domain containing 13 antibody, STARD13 antibody, Stard13 antibody
    Background
    This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.
    Molecular Weight
    124967
    NCBI Accession
    NP_001230395, NP_001230403, NP_001230405, NP_443083, NP_821074, NP_821075
    UniProt
    Q9Y3M8
You are here:
Support